Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Hanmi Pharmaceutical Company Limited"
Count: 181
Selected: 0
NCT IDTitle
NCT05711381Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function
NCT04775706Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects
NCT05656092A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
NCT03089112Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501
NCT04325620Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
NCT04204629Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
NCT05598151Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
NCT04732416HM15136 Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
NCT05555238An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
NCT05548543A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT05548387A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
NCT03666351Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
NCT04505436Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects
NCT05487560An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding
NCT05481307A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
NCT05450601A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
NCT04946903A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
NCT05462535An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet
NCT05024721Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
NCT04959305A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
NCT04762407A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
NCT03897868A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
NCT03826641A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
NCT05450575An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
NCT05422677An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT05407220A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
NCT05362110A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
NCT04768686FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
NCT03284502HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
NCT04032782A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Healthy Subjects
NCT05199129Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
NCT02418689Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
NCT03353350Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
NCT05191563A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
NCT05155995A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
NCT04654702Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
NCT03744182A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLD
NCT04975711Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
NCT04967014Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers
NCT04830449Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
NCT04167553Study for Multiple Doses of HM15136 in Obese or Overweight Subjects With Comorbidities
NCT04829149Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT04764201The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
NCT03332836Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
NCT04820907Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
NCT04788290An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol
NCT04652349Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
NCT02485652Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
NCT04080726Efficacy and Safety of HIP1601 Capsule
NCT04074551A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia